Abincol ® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.

In conclusion, the current survey suggests that Abincol® may be considered an effective and safe therapeutic option in the management of patients with chronic intestinal disorders. PMID: 31292420 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31292420?dopt=Abstract

Source: Acta Bio-Medica : Atenei Parmensis - July 9, 2019 Category: General Medicine Authors: Bonavina L, Arini A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Ciprandi G, On Digestive Disorders ISG Tags: Acta Biomed Source Type: research